Frost & Sullivan Independent Equity Research
BioLineRx Ltd.: Additional Investment by A Principal Investor Reflects a Confidence in the Company. Target Price Unchanged
![bioline bioline](https://www.frostequityresearch.com/wp-content/uploads/elementor/thumbs/bioline-nx7oepmjwr0nqu046yc3t5fs9jyo1sg30b9j97eohk.png)
Company: BioLineRx
Sector: Pharmaceuticals
Report type: Immediate Report
For all past reports click here
Published on: July 30th, 2017